InflaRx develops drugs that block the inflammatory protein C5a, with vilobelimab sold to hospitals for COVID-19 patients. It last closed at $1.04 on Nov 20, down 4.59% on the day.
AI Auto Pilots
Is IFRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IFRX.
From IFRX's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 20). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.
StreetAlpha's call on IFRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
IFRX · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 32% below its 20 day and 53% below its 50 day average. It is 60% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $1.01, and the nearest resistance the Pivot at $1.06.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 12.4%/day
Key levels
$2.9552 week high+183.7%
$1.80100 day average+73.1%
$1.66200 day average+59.6%
$1.61Swing high (Oct 20)+54.8%
$1.5950 day average+52.9%
$1.3820 day average+32.7%
$1.09Pivot R1+4.8%
$1.06Pivot+1.9%
$1.04Last close
$1.01Pivot S1−2.9%
$0.8052 week low−23.1%
Indicators
RSI (14)
26.67
Oversold below 30
Oversold
MACD
-0.15
Below its signal line
Bearish
Stochastic
4.1
Near the bottom of its range
Oversold
ADX (14)
32.5
Trending down
Williams %R
-98.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-100.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−20.3%
Change over 10 sessions
Bearish
ATR (14)
$0.13
Typical daily range, 12.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 31.2%/day
Key levels
$2.9552 week high+183.7%
$1.80100 day average+73.1%
$1.66200 day average+59.6%
$1.61Swing high (Oct 20)+54.8%
$1.5950 day average+52.9%
$1.3820 day average+32.7%
$1.09Pivot R1+4.8%
$1.06Pivot+1.9%
$1.04Last close
$1.01Pivot S1−2.9%
$0.8052 week low−23.1%
Indicators
RSI (14)
36.05
Weak, oversold below 30
Neutral
MACD
-0.12
Below its signal line
Bearish
Stochastic
4.1
Near the bottom of its range
Oversold
ADX (14)
23.4
Weak trend
Williams %R
-99.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-171.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−50.2%
Change over 10 sessions
Bearish
ATR (14)
$0.32
Typical daily range, 31.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IFRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IFRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow IFRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for IFRXHow many large options trades hit IFRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in IFRX in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IFRX is in one of them and how their past IFRX trades turned out.
InflaRx is a biopharmaceutical company based in Jena, Germany, that develops treatments aimed at blocking C5a, a protein that drives inflammation. Its approved product, vilobelimab, is given intravenously and is sold in the U.S. under the name GOHIBIC, where hospitals can order it for critically ill COVID-19 patients. Its lead candidate, izicopan, is taken by mouth and is being studied for chronic skin conditions such as hidradenitis suppurativa and chronic spontaneous urticaria.